Scientific Research Achievements
SCI Papers
| First Author | Corresponding Author | Year | Thesis | Journal | Volume number | Issue Number | Page | Date | Type | ISSN | IF(2018) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Wu Yuanyuan | Miao Jing, Fang Luo | 2022 | Prevalence and predictors of medication non-adherence in children with inflammatory bowel disease in China: A cross-sectional study | FRONTIERS IN PHARMACOLOGY | |||||||
| Jiang Zhouhong, Chen Xuefeng | Fu Junfen, Ni Shaoqing | 2022 | Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study | FRONTIERS IN PHARMACOLOGY | |||||||
| Huang Lingfei, Wang Junyan | Fang Luo, Mao Jianhua | 2022 | Impact of Sampling Time Variability on Tacrolimus Dosage Regimen in Pediatric Primary Nephrotic Syndrome: Single-Center, Prospective, Observational Study | FRONTIERS IN PHARMACOLOGY | |||||||
| Jin Meiyuan | Tang Chao, Xu Shouying | 2022 | Tianma Gouteng Decoction Exerts Pregnancy-Protective Effects Against Preeclampsia via Regulation of Oxidative Stress and NO Signaling | FRONTIERS IN PHARMACOLOGY | |||||||
| Li Ji, Pan Weiwei | Ni Shaoqing, Fu Junfen | 2022 | Metabolomic Differential Compounds Reflecting the Clinical Efficacy of Polyethylene Glycol Recombinant Human Growth Hormone in the Treatment of Childhood Growth Hormone Deficiency | FRONTIERS IN PHARMACOLOGY | |||||||
| Lin Xixi | Xie Yicheng | 2022 | Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance (vol 10, 982, 2019) | FRONTIERS IN PHARMACOLOGY | |||||||
| Li Jiabin, Chen Zhang | Yu Yue,Chen Jingyu | 2022 | The beneficial roles of apelin-13/APJ system in cerebral ischemia: Pathogenesis and therapeutic strategies | FRONTIERS IN PHARMACOLOGY | |||||||
| Ren Yunqing | Zheng Min, Liu Lunfei | 2022 | Genome-wide association analysis of anti-TNF-alpha treatment response in Chinese patients with psoriasis | FRONTIERS IN PHARMACOLOGY | |||||||
| Zhao Jingli | Mao Jianhua | 2022 | The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity | FRONTIERS IN PHARMACOLOGY | |||||||
| Huang Lingfei, Wang Junyan | Fang Luo, Mao Jianhua | 2022 | Impact of sampling time variability on tacrolimus dosage regimen in pediatric primary nephrotic syndrome: Singlecenter, prospective, observational study (vol 12, 726667, 2022) | FRONTIERS IN PHARMACOLOGY |
